Fcc Statement - Beurer BC 57 Mode D'emploi

address or found at the end of the instructions
for use.
• This device corresponds to the EU Medical
Devices Directive 93/42/EEC, the German Med-
ical Devices Act (Medizinproduktgesetz) and
the standards EN 1060-1 (non-invasive sphyg-
momanometers, Part 1: General requirements),
EN 1060-3 (noninvasive sphygmomanometers,
Part3: Supplementary requirements for electro-
mechanical blood pressure measuring systems)
and IEC 80601-2-30 (Medical electrical equip-
ment – Part 2-30: Particular requirements for
the basic safety and essential performance of
automated non-invasive sphygmomanometers).
• The accuracy of this blood pressure monitor
has been carefully checked and developed with
regard to a long useful life. If using the device
for commercial medical purposes, it must be
regularly tested for accuracy by appropri-
ate means. Precise instructions for checking
accuracy may be requested from the service
address.

14. FCC Statement

Changes or modifications to the product not
expressly approved by the party responsible for
compliance could void the user's authority to
operate the equipment.
NOTE: This equipment has been tested and
found to comply with the limits for a Class B dig-
ital device, pursuant to Part 15 of the FCC Rules.
These limits are designed to provide reasonable
protection against harmful interference in a res-
idential installation. This equipment generates,
uses and
can radiate radio frequency energy and, if not
installed and used in accordance with the instruc-
tions, may cause harmful interference to radio
communications. However, there is no guaran-
tee that interference will not occur in a particular
installation. If this equipment does cause harmful
interference to radio or television reception, which
can be determined by turning the equipment off
and on, the user is encouraged to try to correct
30